OBJECTIVES: Since contraception is an effective way of preventing the vertical transmission of HIV, we evaluated the impact of a family planning intervention on hormonal contraceptive use and incident pregnancy in a group of HIV-positive and HIV-negative urban Rwandan women. SUBJECTS AND METHODS: In a longitudinal cohort study, 502 women who were not pregnant or infertile and who had been previously HIV tested and counseled viewed an informational video about hormonal contraception followed by a facilitated discussion. They were given access to oral or injectable hormonal contraception and Norplant at the research clinic; those who used these methods were seen every 3 months. RESULTS: Of the 330 HIV-positive and 172 HIV-negative women who underwent the intervention, 120 either became new hormonal method users (n = 40), continued their previous use of a hormonal method (n = 64), or switched to another hormonal method (n = 16) following the intervention. There was a shift to use of longer lasting hormonal methods, and the annualized attrition rate was < 15%, compared to > 50% prior to the intervention. Rates of oral and injectable contraceptive use were similar among HIV-positive and HIV-negative women. Nine per cent of HIV-positive women became pregnant in the year after the intervention compared to 22% in a prior 12 month period when contraceptives were not provided at the study site. The corresponding proportions for HIV-negative women were 20% after the intervention versus 30% before the intervention. CONCLUSIONS: Access to and information about hormonal contraceptives resulted in increased use and reduced attrition among both HIV-positive and HIV-negative women in this study. The reduction in incident pregnancy was greatest among HIV-positive women, suggesting that factors other than access to hormonal contraceptives may have influenced fertility outcomes. Knowledge of HIV serostatus may have an important influence on family planning decisions.
OBJECTIVES: Since contraception is an effective way of preventing the vertical transmission of HIV, we evaluated the impact of a family planning intervention on hormonal contraceptive use and incident pregnancy in a group of HIV-positive and HIV-negative urban Rwandan women. SUBJECTS AND METHODS: In a longitudinal cohort study, 502 women who were not pregnant or infertile and who had been previously HIV tested and counseled viewed an informational video about hormonal contraception followed by a facilitated discussion. They were given access to oral or injectable hormonal contraception and Norplant at the research clinic; those who used these methods were seen every 3 months. RESULTS: Of the 330 HIV-positive and 172 HIV-negative women who underwent the intervention, 120 either became new hormonal method users (n = 40), continued their previous use of a hormonal method (n = 64), or switched to another hormonal method (n = 16) following the intervention. There was a shift to use of longer lasting hormonal methods, and the annualized attrition rate was < 15%, compared to > 50% prior to the intervention. Rates of oral and injectable contraceptive use were similar among HIV-positive and HIV-negative women. Nine per cent of HIV-positive women became pregnant in the year after the intervention compared to 22% in a prior 12 month period when contraceptives were not provided at the study site. The corresponding proportions for HIV-negative women were 20% after the intervention versus 30% before the intervention. CONCLUSIONS: Access to and information about hormonal contraceptives resulted in increased use and reduced attrition among both HIV-positive and HIV-negative women in this study. The reduction in incident pregnancy was greatest among HIV-positive women, suggesting that factors other than access to hormonal contraceptives may have influenced fertility outcomes. Knowledge of HIV serostatus may have an important influence on family planning decisions.
Entities:
Keywords:
Africa; Africa South Of The Sahara; Behavior; Contraception; Contraceptive Methods; Developing Countries; Diseases; Eastern Africa; Education; Family Planning; Family Planning Education; French Speaking Africa; Hiv Infections--prevention and control; Injectables; Longitudinal Studies; Oral Contraceptives; Research Methodology; Risk Reduction Behavior; Rwanda; Studies; Viral Diseases
Authors: Andrew D Forsyth; Thomas J Coates; Olga A Grinstead; Gloria Sangiwa; Donald Balmer; Munkolenkole C Kamenga; Steven E Gregorich Journal: Am J Public Health Date: 2002-11 Impact factor: 9.308
Authors: Maricianah Onono; Mary A Guzé; Daniel Grossman; Rachel Steinfeld; Elizabeth A Bukusi; Starley Shade; Craig R Cohen; Sara J Newmann Journal: AIDS Care Date: 2015-01-29
Authors: Rob Stephenson; Bellington Vwalika; Lauren Greenberg; Yusuf Ahmed; Cheswa Vwalika; Elwyn Chomba; William Kilembe; Amanda Tichacek; Susan Allen Journal: J Womens Health (Larchmt) Date: 2011-03-16 Impact factor: 2.681
Authors: Rose J Kosgei; Kizito M Lubano; Changyu Shen; Kara K Wools-Kaloustian; Beverly S Musick; Abraham M Siika; Hillary Mabeya; E Jane Carter; Ann Mwangi; James Kiarie Journal: J Acquir Immune Defic Syndr Date: 2011-12-15 Impact factor: 3.731
Authors: Naw H Khu; Bellington Vwalika; Etienne Karita; William Kilembe; Roger A Bayingana; Deborah Sitrin; Heidi Roeber-Rice; Emily Learner; Amanda C Tichacek; Lisa B Haddad; Kristin M Wall; Elwyn N Chomba; Susan A Allen Journal: Contraception Date: 2012-11-12 Impact factor: 3.375
Authors: Sten H Vermund; José A Tique; Holly M Cassell; Megan E Pask; Philip J Ciampa; Carolyn M Audet Journal: J Acquir Immune Defic Syndr Date: 2013-06-01 Impact factor: 3.731
Authors: Kristin M Wall; Bellington Vwalika; Lisa Haddad; Naw H Khu; Cheswa Vwalika; William Kilembe; Elwyn Chomba; Rob Stephenson; David Kleinbaum; Azhar Nizam; Ilene Brill; Amanda Tichacek; Susan Allen Journal: J Acquir Immune Defic Syndr Date: 2013-05-01 Impact factor: 3.731